Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
Postmenopausal women have an increased risk of developing PR(-) ovarian tumors.
»
06/30/16
Activation of UPR Signaling Pathway is Associated With the Malignant Progression and Poor Prognosis in Prostate Cancer.
The expressions of ATF6α, PERK, and IRE1α were significantly associated with Gleason grade.
»
09/02/16
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Duration of progression-free survival significantly longer among those receiving ribociclib plus letrozole.
»
10/09/16
miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.
Over-expression of miR-202 extremely affected the expression of cyclin D1 protein.
»
06/30/16
Dietary Inflammatory Index and Risk of Epithelial Ovarian Cancer in African American Women.
A more pro-inflammatory diet was associated with an increased EOC risk.
»
07/20/16
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients.
Immunohistochemistry analysis of CTLA-4 and p-Akt in pretreatment tumor samples provides useful biomarkers.
»
10/22/16
Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
EVOOE treatment showed a marked growth arrest prior to mitosis.
»
04/29/16
Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells.
A relative reduction in tumor growth.
»
09/23/16
Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.
Use of CCBs was associated with a reduced risk of T2E positive PCa.
»
07/06/16
ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression.
Importance of developing structurally distinct ALK inhibitors.
»
08/21/15
< Prev
Next >